Advertisement
RayBiotech
RayBiotech

Subtle cues prompt cell signals

If you thought that all it took to kick-start a signaling pathway was a ligand binding to a receptor, think again. How and when that binding occurs, it turns out, is what determines what happens inside the cell. In linkurl:a study;http://www.cell.com/content/article/fulltext?uid=PIIS0092867408000470 published online in Cell today, Sherry LaPorte of Stanford University and colleagues describe the structure of the Interleukin-4 and Interleukin-13 (IL-4/13) cytokines and the complete set of recept

By | January 24, 2008

If you thought that all it took to kick-start a signaling pathway was a ligand binding to a receptor, think again. How and when that binding occurs, it turns out, is what determines what happens inside the cell. In linkurl:a study;http://www.cell.com/content/article/fulltext?uid=PIIS0092867408000470 published online in Cell today, Sherry LaPorte of Stanford University and colleagues describe the structure of the Interleukin-4 and Interleukin-13 (IL-4/13) cytokines and the complete set of receptors they bind, including the one receptor complex they have in common. It's not very surprising that different ligands can act on the same receptor to trigger different signal cascades. But the authors' crystal structures reveal that identical receptors can distinguish between ligands that differ only slightly, such as the IL4 and IL-13 molecules. The receptor that IL-4 and IL-13 share is actually a composite of two receptors: the IL-14 receptor α and the IL-13 receptor α. Both are required to initiate a signal, but the IL-4 touches the IL-4 receptor first and with higher affinity, while IL-13 touches the IL-13 receptor first. The researchers think it's this slight difference in the order of contact and affinity that triggers one signaling pathway versus another. Most ligands work by bringing receptors components together at the cell surface. For many receptors, that is sufficient for initiating a signal. This study shows that kick-starting a signaling pathway depends not just on activating the receptor, but also on the intricate differences in movement and binding on the extracellular face of the receptor, writes Alexander Wlodawer from the National Cancer Institute in a linkurl:commentary;http://www.cell.com/content/article/fulltext?uid=PIIS0092867408000615 accompanying the article. Wlodawer, who was not involved in this research, told The Scientist that the study has important implications for linkurl:drug design,;http://www.the-scientist.com/article/display/15706/ since IL-4 and IL-13 initiate specific signaling pathways that are both important in allergy and asthma. Understanding the specific sequence of events that triggers one signal versus another will help drug makers design molecules that mimic that behavior. But, he added, researchers don't yet have the full picture of how molecules at the cell surface interact to determine the specificity and strength of the signal propagated within the cell.
Advertisement

Comments

Avatar of: anonymous poster

anonymous poster

Posts: 11

January 24, 2008

Different entities with similar or same outcomes or specific entities with different outcomes - redundancy and specificity are more of rules than exceptions in biology. Only the simple or stubborn minds of humans insist on the opposite - a dichotomous function of specific entitiy.
Avatar of: Sergio Stagnaro

Sergio Stagnaro

Posts: 59

January 25, 2008

The fascinating article concludes:But, he added, researchers don't yet have the full picture of how molecules at the cell surface interact to determine the specificity and strength of the signal propagated within the cell.\nAs I demonstrated in a lot of papers (Bibliography in www.semeioticabiofisica.it) with the aid of Quantum Biophysical Semeiotics, in biological systems, beside local realm, there is non-local realm, characterized by simultaneous information. For instance, osteocalcin, secreted by bone due to intense digital pressure on vertebrae, is simultaneous to pancreas microcirclulatory activation type I, associated, wherein both vasomotility and vasomotion are increased (= pancreas size increases). Well! Quantum physics highlights such as action mechanism, underlying this FACT, considering non-local realm, simultaneous information, redundancy, and catalytic effect, as suggest by Paolo Manzelly, my precious co-worker.

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
LI-COR
LI-COR
Advertisement
HIWIN
HIWIN